CoChat
Sign Up
Cited by 87

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2

Waschbüsch, Dieter, Purlyte, Elena, Pal, Prosenjit, McGrath, Emma, Alessi, Dario R., Khan, Amir R.·2020·Structure
DOI 10.1016/j.str.2020.01.005PMC PMC7139218

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2020.01.005

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Bardien, 2011, Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease, Parkinsonism Relat. Disord., 17, 501, 10.1016/j.parkreldis.2010.11.008 · DOI
  3. Berndsen, 2019, PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins, Elife, 8, 10.7554/eLife.50416 · DOI · Paper page
  4. Cantalupo, 2001, Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes, EMBO J., 20, 683, 10.1093/emboj/20.4.683 · DOI · Paper page
  5. Dzamko, 2012, The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling, PLoS One, 7, e39132, 10.1371/journal.pone.0039132 · DOI
  6. Emsley, 2010, Features and development of coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  7. Evans, 2013, How good are my data and what is the resolution?, Acta Cryst., D69, 1204
  8. Fahn, 2003, Description of Parkinson's disease as a clinical syndrome, Ann. N. Y Acad. Sci., 991, 1, 10.1111/j.1749-6632.2003.tb07458.x · DOI
  9. Fell, 2015, MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition, J. Pharmacol. Exp. Ther., 355, 397, 10.1124/jpet.115.227587 · DOI
  10. Fujimoto, 2018, Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology, Biochem. Biophys. Res. Commun., 495, 1708, 10.1016/j.bbrc.2017.12.024 · DOI
  11. Gomez, 2019, Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases, J. Cell Biol., 18, 4157, 10.1083/jcb.201902184 · DOI · Paper page
  12. Greggio, 2008, The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation, J. Biol. Chem., 283, 16906, 10.1074/jbc.M708718200 · DOI
  13. Guo, 2013, Intermediates in the guanine nucleotide exchange reaction of Rab8 protein catalyzed by guanine nucleotide exchange factors Rabin8 and GRAB, J. Biol. Chem., 288, 32466, 10.1074/jbc.M113.498329 · DOI
  14. Hanafusa, 2019, LRRK1 phosphorylation of Rab7 at S72 links trafficking of EGFR-containing endosomes to its effector RILP, J. Cell Sci., 132, 10.1242/jcs.228809 · DOI
  15. Hou, 2011, A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1, EMBO J., 30, 1659, 10.1038/emboj.2011.60 · DOI
  16. Hutagalung, 2011, Role of Rab GTPases in membrane traffic and cell physiology, Physiol. Rev., 91, 119, 10.1152/physrev.00059.2009 · DOI · Paper page
  17. Ito, 2016, Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors, Biochem. J., 473, 2671, 10.1042/BCJ20160557 · DOI · Paper page
  18. Jordens, 2001, The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors, Curr. Biol., 11, 1680, 10.1016/S0960-9822(01)00531-0 · DOI · Paper page
  19. Kabsch, 2010, Integration, scaling, space-group assignment and post-refinement, Acta Crystallogr. D. Biol. Crystallogr., 66, 133, 10.1107/S0907444909047374 · DOI
  20. Karayel, 2019, Accurate MS-based Rab10 phosphorylation stoichiometry determination as readout for LRRK2 activity in Parkinson’s disease, bioRxiv
  21. Kelkar, 2005, Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways, Mol. Cell Biol., 25, 2733, 10.1128/MCB.25.7.2733-2743.2005 · DOI · Paper page
  22. Khan, 2013, Structural biology of Arf and Rab GTPases' effector recruitment and specificity, Structure, 21, 1284, 10.1016/j.str.2013.06.016 · DOI
  23. Krissinel, 2004, Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions, Acta Crystallogr. D Biol. Crystallogr., 60, 2256, 10.1107/S0907444904026460 · DOI
  24. Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr. D Struct. Biol., 75, 861, 10.1107/S2059798319011471 · DOI · Paper page
  25. Lindsay, 2013, Identification and characterization of multiple novel Rab-myosin Va interactions, Mol. Biol. Cell, 24, 3420, 10.1091/mbc.e13-05-0236 · DOI
  26. Lise, 2009, Myosin-Va-interacting protein, RILPL2, controls cell shape and neuronal morphogenesis via Rac signaling, J. Cell Sci., 122, 3810, 10.1242/jcs.050344 · DOI
  27. Liu, 2018, LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network, Hum. Mol. Genet., 27, 385, 10.1093/hmg/ddx410 · DOI · Paper page
  28. McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  29. McGrath, 2019, LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain, Small GTPases, 1
  30. Mehta, 2014, The cellular and physiological functions of the Lowe syndrome protein OCRL1, Traffic, 15, 471, 10.1111/tra.12160 · DOI
  31. Paisan-Ruiz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 · DOI
  32. Purlyte, 2017, Rab29 activation of the Parkinson's disease-associated LRRK2 kinase, EMBO J., 4, 1
  33. Roosen, 2016, LRRK2 at the interface of autophagosomes, endosomes and lysosomes, Mol. Neurodegener., 11, 73, 10.1186/s13024-016-0140-1 · DOI
  34. Schaub, 2013, The Rilp-like proteins Rilpl1 and Rilpl2 regulate ciliary membrane content, Mol. Biol. Cell, 24, 453, 10.1091/mbc.e12-08-0598 · DOI
  35. Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 · DOI · Paper page
  36. Schulte, 2011, Genetic basis of Parkinson's disease: inheritance, penetrance, and expression, Appl. Clin. Genet., 4, 67
  37. Steger, 2017, Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis, Elife, 6, e31012, 10.7554/eLife.31012 · DOI · Paper page
  38. Steger, 2016, Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases, Elife, 5, e12813, 10.7554/eLife.12813 · DOI · Paper page
  39. Vieweg, 2019, PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2 mediated phosphorylation at threonine72, bioRxiv
  40. Vilela, 2019, Structural characterization of the RH1-LZI tandem of JIP3/4 highlights RH1 domains as a cytoskeletal motor-binding motif, Sci. Rep., 9, 16036, 10.1038/s41598-019-52537-3 · DOI
  41. Waschbusch, 2014, LRRK2 transport is regulated by its novel interacting partner Rab32, PLoS One, 9, e111632, 10.1371/journal.pone.0111632 · DOI
  42. Wei, 2013, Structural basis of cargo recognitions for class V myosins, Proc. Natl. Acad. Sci. U S A, 110, 11314, 10.1073/pnas.1306768110 · DOI
  43. West, 2016, Identification of bona-fide LRRK2 kinase substrates, Mov. Disord., 31, 1140, 10.1002/mds.26647 · DOI
  44. Williams, 2018, MolProbity: more and better reference data for improved all-atom structure validation, Protein Sci., 27, 293, 10.1002/pro.3330 · DOI · Paper page
  45. Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
  46. Wu, 2005, Structural basis for recruitment of RILP by small GTPase Rab7, EMBO J., 24, 1491, 10.1038/sj.emboj.7600643 · DOI
  47. Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Waschbüsch, D., Purlyte, E., Pal, P., McGrath, E., Alessi, D. R., & Khan, A. R.
Venue
Structure
Publisher
Elsevier BV
Published
2020-04
Volume
28
Issue
4
Pages
406-417.e6
ISSN
0969-2126
DOI
10.1016/j.str.2020.01.005
PMC
PMC7139218
Cited by
87
References
3
Language
en
Licence
Funders
  • Office of Research Infrastructure Programs, National Institutes of Health (S10 RR029205)
  • National Institutes of Health (S10 RR029205)
  • Science Foundation Ireland (12/IA/1239, 6986)
  • Argonne National Laboratory (DE-AC02-06CH11357)
  • Medical Research Council (MC_UU_12016/2)
  • National Institute of General Medical Sciences (P41 GM103403)
  • GlaxoSmithKline
  • Office of Science
  • Michael J. Fox Foundation for Parkinson's Research
  • Merck KGaA
  • U.S. Department of Energy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review